Back
Corcept Therapeutics Quote, Financials, Valuation and Earnings
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!
Buy
78
CORT
Corcept Therapeutics
Last Price:
52.14
Seasonality Move:
3.97%
7 Day Trial
ALL ACCESS PASS
$
7
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!Corcept Therapeutics Price Quote
$52.14
Corcept Therapeutics Key Stats
Buy
78
Corcept Therapeutics (CORT)
is a Buy
Day range:
$49.51 - $52.35
52-week range:
$20.84 - $51.32
Dividend yield:
0%
P/E ratio:
53.27
P/S ratio:
8.88
P/B ratio:
8.21%
Volume:
1.2M
Avg. volume:
1.1M
1-year change:
103.51%
Market cap:
$5.2B
Revenue:
$482.4M
EPS:
$1.26
How Much Does Corcept Therapeutics Make?
-
How Much Are Corcept Therapeutics's Sales Annually?
CORT Revenues are $482.4M -
How Much Profit Does Corcept Therapeutics's Make A Year?
CORT net income is $106.1M
Is Corcept Therapeutics Growing As A Company?
-
What Is Corcept Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.48% -
What Is Corcept Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0.46%
Corcept Therapeutics Stock Price Performance
-
Did Corcept Therapeutics Stock Go Up Last Month?
Corcept Therapeutics share price went up by 14.77% last month -
Did CORT's Share Price Rise Over The Last Year?
CORT share price rose by 103.51% over the past 1 year
What Is Corcept Therapeutics 52-Week High & Low?
-
What Is Corcept Therapeutics’s 52-Week High Share Price?
Corcept Therapeutics has traded as high as $51.32 over the past 52 weeks -
What Is Corcept Therapeutics’s 52-Week Low Share Price?
Corcept Therapeutics has traded as low as $20.84 over the past 52 weeks
Corcept Therapeutics Price To Free Cash Flow
-
Is Corcept Therapeutics Stock Overvalued?
Corcept Therapeutics is trading at a price to free cash flow ratio of 39.12 -
Is Corcept Therapeutics Stock Undervalued?
Corcept Therapeutics EV to Free Cash Flow ratio is 34.12 -
What Is Corcept Therapeutics’s Price Earnings Growth Ratio?
CORT PEG ratio is 0.72 -
Is Corcept Therapeutics Trading At A Premium To Earnings?
Corcept Therapeutics EV to EBIT ratio is 33.94
Is It Risky To Buy Corcept Therapeutics?
-
How Much Debt Does Corcept Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Corcept Therapeutics Have?
Cash and short term investments quarterly total is $380.3M -
What Is Corcept Therapeutics’s Book Value Per Share?
Book value per share is 6.10
Is Corcept Therapeutics Cash Flow Positive?
-
What Is CORT Cash Flow From Operations?
Cash flow from operations (TTM) is $144.7M -
What Is Corcept Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$23M -
What Is Corcept Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$96.1M
Corcept Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
CORT return on invested capital is 25.77% -
What Is Corcept Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is 21.04% -
What Is CORT Return On Equity?
ROE is a measure of profitability and is 25.77%
Corcept Therapeutics Earnings Date & Stock Price
-
What Is Corcept Therapeutics's Stock Price Today?
A single share of CORT can be purchased today for 52.14 -
What Is Corcept Therapeutics’s Stock Symbol?
Corcept Therapeutics trades on the nasdaq under the ticker symbol: CORT -
When Is Corcept Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Corcept Therapeutics is scheduled on February 14, 2025 -
When Is CORT's next ex-dividend date?
Corcept Therapeutics's next ex-dividend date is November 6, 2024 -
How To Buy Corcept Therapeutics Stock?
You can buy Corcept Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Corcept Therapeutics Competitors
-
Who Are Corcept Therapeutics's Competitors?
Below is a list of companies who compete with Corcept Therapeutics or are related in some way:
Corcept Therapeutics Dividend Yield
-
What Is CORT Dividend Yield?
Corcept Therapeutics’s dividend yield currently is 0% -
What Is Corcept Therapeutics’s Payout Ratio?
Corcept Therapeutics’s payout ratio is 0% -
When Did Corcept Therapeutics Last Pay A Dividend?
The latest dividend pay date is November 6, 2024 -
What Is Corcept Therapeutics’s Dividend Per Share?
Corcept Therapeutics pays a dividend of $0.00 per share
Corcept Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 46.43% | 41.38% |
| Revenue: | 47.69% | 6.15% |
Analyst Recommendations
| Buy Recommendations: | 3 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 74.90 |
| Upside from Last Price: | 43.65% |